SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma informs about investors conference

18 Jun 2022 Evaluate

Aurobindo Pharma has informed that S. Subramanian, Chief Financial Officer of the Company, will be participating in group investors conference (virtual) arranged by SNP Pari bas on 20th June 2022 at 13:30-14:20 hrs IST. No unpublished price sensitive information (UPSI) is intended to be discussed during the conference. This information is submitted pursuant to Regulation 30(6) of the Listing Regulations. The changes may happen in the schedule of the aforesaid conference due to exigencies on the part of Participants / Company.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1620.10 60.05 (3.85%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: